Abstract
One hundred and two patients with inoperable bronchial carcinoma who had tuberculin tests at the time of diagnosis were followed up to see if there was any correlation between their degree of tuberculin reactivity and their subsequent survival time. There was a significant difference in survival between positive and negative tuberculin reactors (Log Rank Test P less than 0.05), the former having a median survival time almost twice that of the latter. This did not appear to be related to clinical differences between the groups at the time of testing, and other possible explanations are discussed. Tuberculin testing may be useful in helping to assess prognosis in patients with inoperable bronchial tumours.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blomgren H., Baral E., Petrini B., Wasserman J. Impaired lymphocyte responses to PPD-tuberculin in advanced breast carcinoma. Increased reactivity after depletion of phagocytic or adherent cells. Clin Oncol. 1976 Dec;2(4):379–392. [PubMed] [Google Scholar]
- Bonchek L. I. Diagnosis of lung cancer in tuberculous patients. Use of tuberculin skin test and serum protein electrophoresis. Chest. 1971 Sep;60(3):256–259. doi: 10.1378/chest.60.3.256. [DOI] [PubMed] [Google Scholar]
- Chahinian P. Relationship between tumor doubling time and anatomoclinical features in 50 measurable pulmonary cancers. Chest. 1972 Apr;61(4):340–345. doi: 10.1378/chest.61.4.340. [DOI] [PubMed] [Google Scholar]
- Hughes L. E., Mackay W. D. Suppression of the tuberculin response in malignant disease. Br Med J. 1965 Dec 4;2(5474):1346–1348. doi: 10.1136/bmj.2.5474.1346. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Israel L., Bouvrain A., Cros-Decam J., Mugica J. Contribution à l'étude des phénomènes d'immunité cellulaire chez les cancéreux pulmonaires avant traitement palliatif ou chirurgical. Poumon Coeur. 1968;24(3):339–350. [PubMed] [Google Scholar]
- Israel L., Mugica J., Chahinian P. Prognosis of early bronchogenic carcinoma. Survival curves of 451 patients after resection of lung cancer in relation to the results of pre-operative tuberculin skin test. Biomedicine. 1973 Feb 10;19(2):68–72. [PubMed] [Google Scholar]
- Krant M. J., Manskopf G., Brandrup C. S., Madoff M. A. Immunologic alterations in bronchogenic cancer. Sequential study. Cancer. 1968 Apr;21(4):623–631. doi: 10.1002/1097-0142(196804)21:4<623::aid-cncr2820210414>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
- Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stott H., Peto J., Stephens R., Fox W. An assessment of the carcinogenicity of isoniazid in patients with pulmonary tuberculosis. Tubercle. 1976 Mar;57(1):1–15. doi: 10.1016/0041-3879(76)90014-3. [DOI] [PubMed] [Google Scholar]